These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3939123)

  • 1. Effects of MT-141, a new cephamycin antibiotic, on acute urinary tract infections.
    Miyamoto S; Tamiya T; Takatsuka K; Kumamoto Y
    Drugs Exp Clin Res; 1985; 11(6):379-82. PubMed ID: 3939123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of rapid bacteriological response to MT-141 and latamoxef in complicated urinary tract infections.
    Miyamoto S; Tamiya T; Takatsuka K; Kumamoto Y
    Drugs Exp Clin Res; 1985; 11(6):383-5. PubMed ID: 3939124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefminox versus cefotaxime in the treatment of complicated urinary tract infection].
    Gastón de Iriarte E; Cárcamo Valor P; Diez-Enciso M; Prieto Prieto J; Pérez Balcabao I; Gimeno del Sol M; Coronel Granado P; Morán Soto MJ
    Actas Urol Esp; 1995 Sep; 19(8):635-41. PubMed ID: 8669331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experience with cefmetazole in the urological field].
    Aga Y; Yano M; Ogura K
    Hinyokika Kiyo; 1983 Apr; 29(4):459-63. PubMed ID: 6587763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Microbiological, kinetic and clinical study on a new cephamycin: cefotetan].
    Soranzo ML; Capra E; Eandi M; Angela GC; Musso E; Bendiscioli L; Salassa B; Braida M; Lollini P; Pizzo L; Cignolo G; Spezia C; Andreoni G; Bramato C; di Nola F
    Minerva Med; 1983 Jun; 74(27):1639-50. PubMed ID: 6343925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment of urinary tract infections.
    Kumazawa J; Momose S; Nakamuta S
    Clin Ther; 1981; 4 Suppl A():18-24. PubMed ID: 6275995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
    Verbist L
    Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose cefotetan for urinary tract infection.
    Sanderson PJ
    Pharmatherapeutica; 1985; 4(5):332-4. PubMed ID: 3906676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of serious urological infections with cefotaxime compared to ampicillin plus netilmicin.
    Rasmussen D; Bremmelgaard A; Rasmussen F; Thorup J
    Dan Med Bull; 1986 Feb; 33(1):49-51. PubMed ID: 3948539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime and cefazolin in the treatment of complicated urinary tract infections: a comparative study.
    Madsen PO; Iversen P
    Clin Ther; 1981; 4(1):7-11. PubMed ID: 6268298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Moxalactam - a beta-lactam antibiotic in the monotherapy of severe infections in surgery. Clinico-bacteriological study of 35 patients].
    Gonzenbach HR; Sonnabend W
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1169-83. PubMed ID: 6456543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience in the treatment of complicated urinary tract infection with different doses of moxalactam (lamoxactam).
    Hautmann R; Pranada F; Ahlert G
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):209-12. PubMed ID: 6222995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefotaxime, ceftizoxime, cefmenoxime, and latamoxef in comparison with other beta-lactam antibiotics against recent clinical isolates of Haemophilus influenzae and Haemophilus parainfluenzae.
    Kawakami Y; Okimura Y; Horiuchi N; Kanai M
    Microbiol Immunol; 1982; 26(7):617-21. PubMed ID: 6290854
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotaxime in a single daily dose in lower urinary tract infections.
    Peralta S; Affronti M; Malta R; Delle Vedove G; Pirrotta P; Rotondo G; Paternostro D; Rini GB; Di Rosa S
    J Chemother; 1989 Jul; 1(4 Suppl):847-8. PubMed ID: 16312666
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance of Listeria to cefotaxime and moxalactam.
    Rotstein C; Farrar WE
    Can Med Assoc J; 1982 Aug; 127(4):277. PubMed ID: 6284331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.